Construction of the "Patient-Centered"Molecular Pathology Diagnostic Center
1 other identifier
observational
1,500
1 country
1
Brief Summary
The investigators want to achieve the goal of diagnosis in early phase, accurate treatment and existence for a long period in order to screen in early phase, diagnose in clinical trial, choose treatment and evaluate prognosis of cancers by establishing molecular pathology tools.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 6, 2011
CompletedFirst Posted
Study publicly available on registry
March 9, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedMarch 9, 2011
March 1, 2011
March 6, 2011
March 8, 2011
Conditions
Keywords
Eligibility Criteria
cancer patients
You may qualify if:
- above 20 years old
- all kinds of cancer patients
You may not qualify if:
- under 20 years old
- none cancer patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
TMU-CECR
Taipei, Taiwan
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Wen-Ta Chiu
TMU-CECR
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 6, 2011
First Posted
March 9, 2011
Study Start
August 1, 2010
Study Completion
December 1, 2013
Last Updated
March 9, 2011
Record last verified: 2011-03